Lipid-soluble thiamine derivatives in the treatment of autism
AssigneeWestlake Laboratories, Inc.
InventorsDerrick Lonsdale, James P. Frackelton
Life of this patent
Estimating the term…
Abstract
The present invention is directed to a method for the treatment of autism comprising administering to a person in need of such treatment a therapeutically effective amount of a lipid-soluble thiamine derivative. The lipid-soluble thiamine derivative is preferably tetrahydrofurfuryl disulfide (TTFD). TTFD administration methods may include suppository forms, transdermal carriers, such as gels, lotions, or creams; and oral carriers, such as tablets or capsules.
Claims14
A method of treating autism comprising administering a therapeutically effective amount of a lipid-soluble thiamine derivative to a person in need of such treatment.
A method of treating autism comprising administering a therapeutically effective amount of a lipid-soluble thiamine derivative to a child in need of such treatment.
A method of treating autism comprising rectally administering a therapeutically effective amount of a lipid-soluble thiamine derivative to a child in need of such treatment.
A method of treating autism comprising rectally administering a suppository comprising a therapeutically effective amount of a lipid-soluble thiamine compound to a child in need of such treatment.
Dependencies are inferred from the claim text.